← All organizations
Highest phase reached
Phase 3
First clinical trial
May 12, 2022Last known activity
Sep 12, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (8 distinct, 3 trials)
Phase 3 (5 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Recent trials (6)
- NCT07245095Lead sponsorPhase 2Sep 12, 2025
- NCT06622525OfficialN/AMay 1, 2024
- NCT06622525Lead sponsorN/AMay 1, 2024
- NCT05398055Lead sponsorPhase 3May 12, 2022
- NCT05398055Overall official - principal investigatorPhase 3May 12, 2022
- NCT05398055Reponsible party - principal investigatorPhase 3May 12, 2022
Details
- Last known activity
- Sep 12, 2025